ReviewBreast (Edinburgh, Scotland)2022

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer.

Elie Rassy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.